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Adverse drug reactions in internal medicine units at a university hospital:
A descriptive pilot study
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SUMMARY
Introduction: Adverse drug reactions (ADRs) are an important cause of morbidity and mortality among hospitalized
patients.
Objectives: This study was designed to describe the frequency, severity, and causality of ADRs in internal medicine units
at a third-level university hospital.
Materials and methods: A descriptive study was performed at internal medicine units, by means of a structured format,
review of clinical records, and interview of hospitalized patients. The Naranjo algorithm was applied to patient adverse events
to define causality. Additionally, ADRs were classified according to the Rawlins and Thompson criteria.
Results: One hundred patients (50 men and 50 women) were included in the study. Ninety nine (99) adverse events were
found among the patients. The Naranjo algorithm was applied to adverse events, resulting in twenty nine (29) probable ADRs,
twenty (20) possible ADRs and fifty (50) doubtful ADRs. Cardiovascular drugs and antibiotics were the most frequent
therapeutic groups associated with ADRs. In addition, two preventable medication errors were identified.
Conclusions: Frequency of ADRs was similar to the number reported in other studies in internal medicine units. It is
necessary to systematize efforts of pharmacological surveillance in hospital wards, toward an opportune detection and
prevention of ADRs.
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RESUMEN
Introducción: Las reacciones adversas a medicamentos (RAM) son una importante causa de morbilidad y mortalidad en
pacientes hospitalizados.
Objetivos: Este estudio se diseñó para describir la frecuencia, severidad y causalidad de las RAM en las salas de Medicina
Interna de un hospital universitario de tercer nivel.
Materiales y métodos: Se realizó un estudio descriptivo en las salas de hospitalización de Medicina Interna, con un formato
estructurado, revisión de historia clínica y entrevista a los pacientes. Para definir causalidad, se aplicó el algoritmo de Naranjo
a los eventos adversos de los enfermos. Además, se clasificaron las RAM de acuerdo con los criterios de Rawlins y Thompson.
Resultados: En el estudio se incluyeron 100  pacientes (50 hombres y 50 mujeres). Se informaron 99 sucesos  adversos;
con el algoritmo de Naranjo se clasificaron como RAM probables (n=29), RAM posibles (n=21) y RAM dudosos (n=49). Los
medicamentos cardiovasculares y los antibióticos fueron los grupos terapéuticos más relacionados con efectos adversos. Se
descubrieron dos errores de medicación prevenibles.
Conclusiones: La frecuencia que se encontró de estas reacciones adversas  fue similar a la que informaron otras investi-
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gaciones en servicios de Medicina Interna. Es necesario
sistematizar los esfuerzos de fármaco-vigilancia hospitalaria
para prevenir y evitar oportunamente las RAM.
Palabras clave: Farmacovigilancia; Reacciones adversas
a medicamentos; Pacientes hospitalizados.
The World Health Organization (WHO) defines
adverse drug reactions (ADRs) as «any harmful or
undesired response to a medication, occurring at doses
used for prophylaxis, diagnosis, and treatment in
humans»1. In the United States, ADRs were classified
between the fourth and sixth cause of death in 1994,
after cardiovascular disease, cancer, accidents, and
violence2.
The significant increase of medications commercially
available in recent years has generated numerous
epidemiological studies aimed at determining the severity,
incidence, and direct and indirect costs of ADRs in
hospital and ambulatory settings. In hospitalized patients
prevalence of ADRs has been reported ranging from
1.2% to 45%, the broad variability of prevalence reported
in studies is due primarily to methodological differences
in the collection of data and in the use of non-standardized
criteria to diagnose the presence of adverse effects to
medications2-4. Most research in detecting ADRs has
been undertaken in the USA and Europe, with insufficient
data on adverse effects in populations in Latin American
nations.
Some studies in Latin America have been developed
to investigate ADRs. Recently, Tribiño et al., reported
an incidence of 25.1% of adverse effects in hospitalized
patients in internal medicine wards at a third-level
hospital in Bogotá, finding that patients with ADRs
presented greater hospitalization stays that directly or
indirectly increased hospital costs5. In Brazil, a cohort
study reported that 43% of hospitalized patients displayed
adverse reactions to at least one medication in third-
level internal medicine wards6. The high frequency of
ADRs in internal medicine wards is due mainly because
patients are usually elderly, have multiple chronic illnesses,
and are treated with more than two medications
(polypharmacy), placing them at higher risk of adverse
effects and drug-drug and drug-illness interactions7-9.
In Colombia and in other Latin American nations, the
prevalence, incidence, and mortality of ADRs in
hospitalized patients is unknown, in part because of the
lack of pharmacological surveillance studies and
insufficient reporting of adverse events to the Instituto
Nacional de Vigilancia de Medicamentos y Alimen-
tos (INVIMA) [National Institute of Food and Drug
Surveillance]. This study was conducted to describe the
incidence and the clinical characteristics of the ADRs in
internal medicine hospital wards at a university hospital.
Additionally, the groups of medications most frequently
associated to ADRs were identified, along with the
severity of the adverse reactions, potentially preventable
adverse effects, and unfavorable drug-drug and drug-
illness interactions.
MATERIALS AND METHODS
Population of study. A descriptive study was done
at a third-level university hospital located in Cali, Colom-
bia. The hospital has a total of 698 beds, of which 59
correspond to the internal medicine hospitalization
service. The study randomly included patients over 18
years of age from both sexes, admitted to the service of
internal medicine wards during June, July, and August
2006. Patients who did not present indications of ADRs
at admission were included, and who accepted
participating in the study; excluding those who revealed
communication difficulties, confused or disoriented
patients on neurological examination, patients transferred
from other hospitalization services, and those who refused
to participate in the study.
Based on the data prior to admission to the ward from
the previous year (785 men and 824 women), the
average monthly admission (65.4 and 68.6, respectively),
and the expected incidence of ADRs of 25%; a sample
of 140 patients was calculated. At the end of three
months of data collection, 40 patients were excluded
because they presented at least one of the exclusion
criteria, resulting in a total study population of 100
patients, 50 in the male ward and 50 in the female ward.
This project was approved by the Committee of
Human Ethics of the Faculty of Health at Universidad
del Valle (act Nº 04 of 2006) and by the Ethics Committee
at the University Hospital (24 May 2006).
Data collection. Data was gathered via a format
designed to detect ADRs. The form was filled out
through a semi-structured interview of the patient,
review of the medical history, and direct communication
with medical personnel rotating in the ward. The form
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included the following data: 1. Identification of the
patient; 2. Current diagnosis and at time of admission to
the internal medicine ward; 3. Symptoms presented
during hospitalization, including date of onset; 4.
Laboratory exams; 5. Medications used before and
during the hospitalization.
Data analysis. The medications were catalogued
according to the Anatomical Therapeutic Chemical
(ATC) classification. The International Statistical
Classification of Diseases and Related Problems
(ICD-10) was employed to classify diseases. The
symptoms, signs, and laboratory findings obtained for
each patient were evaluated with the Naranjo algorithm
to determine causality between the drug and the adverse
event presented10. For definition purposes of adverse
drug reaction, only adverse events classified as definite,
probable, and possible were defined with respect to the
administering of a medication. The Naranjo algorithm
was independently performed by two researchers (JR,
MP). In cases of patients where a classification different
to ADRs was found by the two evaluators, the format
was and the medical history were again reviewed, and
a new interview was given to the patient to determine by
consensus the presence or absence of ADRs (Figure 1).
The classification of adverse reactions was done
according to the Rawlins and Thompson criteria in
categories A and B9. The categorization is done according
to the severity of the adverse reaction, the predictability
according to the action mechanism of the drug, the
relationship with the dose, the duration of the treatment,
and the time transpired for the appearance of the
adverse effect after administering the medication. The
determination of the preventable adverse effects and
the classification of the severity was fulfilled as previously
described by Dormann et al.11,12.
RESULTS
The study included 100 patients, of which 50 were
male and 50 were female with average age of 42.95
years (IC 95% ± 13.41). The hospital stay at the internal
medicine ward for the sample was 10.07 (IC 95% ± 7.2),
Figure 1. Methodology for detection and classification of ADRs
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with an average of medications administered of 7.77 (IC
95% ± 2.9). The first five causes of hospitalization
correspond to cardiovascular disease (HTA, 25%; acute
coronary disease, 12%; and heart failure, 10%), chronic
renal insufficiency (16%), and AIDS (12%). The groups
of medications prescribed most were cardiovascular
drugs and analgesics. In the study, 99 adverse events
were identified related to medications in 45 patients (IC
95%, 35.1-54.9), corresponding to probable ADRs
(n=29), possible ADRs (n=21), and doubtful ADRs
(n=49), after applying the Naranjo algorithm. None of
the adverse events was classified as definite. Additionally,
doubtful ADRs were not considered adverse effects to
medications. In five patients, two ADR events were
present simultaneously.
The cardiovascular medications are associated with
the greatest number of adverse effects. Of these,
enalapril caused the greatest ADRs, consisting of dry
cough (n=9), coetaneous rash (n=1), and pharmacological
interactions with other cardiovascular medications (n=2),
followed by amlodipine (n=8), furosemide (n=6),
clindamycin (n=4), lovastatin (n=3), and ceftriaxone
(n=3). All ADRs associated with enalapril were
catalogued as slight. Other cardiovascular medications
related to ADRs were amlodipine and furosemide that
mainly caused palpitations and orthostatic hypotension
(n=12). Additionally, the antilipemic lovastatin was
associated to myalgia in three patients. The second
group of medications most frequently linked to ADRs
was antibiotics, primarily clindamycin and ceftriaxone,
both associated with diarrhea and coetaneous rash.
According to the classification by Rawlins and
Thompson, 92% of the ADRs found in the Ward were
classified as type A adverse effects (dose dependent,
predictable, common) and the remaining 8% were
classified as type B (dose independent, unpredictable,
uncommon). All the type B adverse effects described in
the ward corresponded to maculopapular rash related
with the administering of clindamycin (3 patients) and
ceftriaxone (1 patient).
Adverse reactions were also classified by systems
(Table 1). The system where the greatest number of
ADRs was the gastrointestinal system, present in 36%
of all the cases, which consisted mainly of nausea and
vomit (8 patients) secondary to the administering of
opioids, antineoplastics, and antibiotics. Five patients
presented diarrhea secondary to the use of antibiotics
and in four patients constipation was associated to the
administering of opioids, tricyclic antidepressants, and
antacids. Joint administering of acetylsalicylic acid and
clopidogrel caused melenas in one patient.
Other systems commonly affected by ADRs were
the cardiovascular system (orthostatic hypotension and
palpitations by antihypertensives), the respiratory system
(cough secondary to IECAs), the skin (rash secondary
to antibiotics and IECAs) and the muculoskeletal system
(myalgia secondary to Statins). Only two cases were
detected of adverse effects in the hydroelectrolitic
balance, both related to hypokalemia because of diuretics.
In the central nervous system, the study detected one
case of sedation related to the use of pregabalin. No
hematologic (anemia, thrombocytopemia, neutropenia),
hepatic (hepatoxicity), or renal (nephrotoxicity) adverse
effects were detected secondary to the use of
medications in the ward.
Thirteen adverse reactions were identified related to
the simultaneous use of two or more medications. Six
patients presented orthostatic hypotension and palpitations
caused by the combination of antihypertensive
medications; primarily the simultaneous use of
vasodilators and diuretics. In four patients, diarrhea was
related to the simultaneous use of two antibiotics. In one
asthmatic patient with cardiac insufficiency, the study
detected hypokalemia secondary to the administering of
furosemide and ? 2 agonists, which was diagnosed and
treated opportunely. The rest of the adverse effects
related to drug interactions are described in Table 2.
A case was identified with errors in the administration
of the medication, corresponding to the irregular
administering of clonidine, without presenting significant
variations in blood pressure and one case of medication
combination requiring close monitoring, which consisted
in the concomitant use of genfibrozil with lovastatin
without evidencing myalgia or other signs that would
indicate the presence of rhabdomyolysis in this patient.
DISCUSSION
In the current study, a descriptive analysis was
performed of the adverse reactions to medications at an
internal medicine service. In gathering the data, we
were aware that the medical history could have
incomplete information; hence, the medications
prescribed to each patient (presentation, dose, and route
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Table 1
Shows frequency, type of adverse effect and the medications associated with ADRs
according to the system involved
System                Total N°             Type of adverse effect     Medications responsible for ATC classification

































Sulfonamides and trimethoprim (2)
Antineoplasics and inmunomodulators (2)
Tricyclic antidepressants (1)
Drug interaction (1)














of administration) were confirmed by the format of
medication administration used by nursing personnel
and by the physicians responsible for the ward. In spite
of the limitation in collecting data through the medical
history, previous studies of pharmacological surveillance
have described a high correlation between medications
administered to patients and those registered in the
medical history13.
Active pharmacological surveillance in hospital
settings presents multiple advantages with respect to
programs of voluntary notification of adverse effects.
The strategy for detecting adverse effects applied in this
study permits obtaining complete information of the
patient’s illness and the drugs administered. Additionally,
this methodology permits checking the veracity of the
data related to the administration of the medication
(dose, commercial presentation, route of administration,
date of prescription) indispensible in determining if there
is or isn’t causality of an adverse effect. This system of
pharmacological surveillance is low cost and can be
easily applied in hospitalization services in Latin American
nations to increase the prevention and early detection of
adverse effects in hospitalized patients14.
This study did not detect serious adverse effects in
patients hospitalized in the internal medicine ward; this
is only explained in part by some limitations of the
methodology. In the first place, simple size is insufficient
to detect serious adverse effects, given that it was
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calculated based on a 25% frequency of all types of
ADRs and not based on the frequency estimated of 1 to
2% of serious ADRs. In the second place, the study did
not conduct follow up of the patients, which could
diminish detecting infrequent ADRs.
Cough secondary to the use of enalapril was the most
common adverse effect related to an individual drug.
This can be explained because cough occurs in 20 to
30% of the individuals who consume Inhibitors of
Angiotensin Converting Enzyme (IACEs), and 29% of
the patients in the ward were being treated with
enalapril15,16. The high frequency of orthostatic
hypotension associated to the use of antihypertensives
may be due to the characteristics of the patients in the
ward, where the most frequent diagnoses are
cardiovascular diseases like hypertension, cardiac
insufficiency, and acute myocardial infarction.
It is necessary to conduct studies with a greater
number of patients to determine preventable risks with
the use of medications in internal medicine hospitalization
services, since the current study found two situations
that are potentially related with adverse reactions, that
if they were to occur they could be classified as serious
or severe. These efforts should be frame worked within
an ordered program of pharmacological surveillance,
which should be organized foremost in compliance with
Decree 2200 of 2005 from the Ministry of Social
Protection and from the responsibility of this being a
teaching institution, which brings challenges as well as
advantages in its introduction.
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